IBM (IBM)

Total Costs & Expenses

$56.75B

TTM · Period ending: · USD

IBM logo

IBM Total Costs & Expenses

Latest reported$56.75B
IBM TTM Total Costs & Expenses ($43.39B → $56.75B)
High-resolution chart · PNG

IBM total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

IBM Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
56,754,000,000
56,098,000,000
55,176,000,000
53,990,000,000
53,109,000,000
52,553,000,000
52,675,000,000
52,408,000,000
52,266,000,000
52,128,000,000
52,046,000,000
51,853,000,000
51,750,000,000
52,128,000,000
52,325,000,000
52,854,000,000
52,224,000,000
51,268,000,000
50,486,000,000
53,134,000,000
56,371,000,000
59,665,000,000
63,817,000,000
64,959,000,000
65,910,000,000
66,789,000,000
66,566,000,000
65,991,000,000
65,177,000,000
65,120,000,000
66,304,000,000
67,259,000,000
67,724,000,000
67,397,000,000
66,314,000,000
65,190,000,000
65,283,000,000
65,835,000,000
66,728,000,000
66,894,000,000
66,696,000,000
66,438,000,000
65,826,000,000
67,189,000,000
69,452,000,000
71,449,000,000
73,928,000,000
76,289,000,000
76,681,000,000
78,731,000,000
79,456,000,000
79,313,000,000
81,148,000,000
81,032,000,000
82,065,000,000
83,946,000,000
84,998,000,000
86,247,000,000
86,642,000,000
86,578,000,000
85,269,000,000
82,839,000,000
81,729,000,000
80,601,000,000
80,141,000,000
79,883,000,000
78,842,000,000
79,071,000,000
81,087,000,000
85,064,000,000
87,566,000,000
89,632,000,000
89,205,000,000
87,033,000,000
85,269,000,000
83,534,000,000
82,313,000,000
80,628,000,000
79,496,000,000
78,106,000,000
77,186,000,000
79,341,000,000
81,758,000,000
84,745,000,000
87,321,000,000
86,840,000,000
86,151,000,000
84,952,000,000
82,826,000,000
81,157,000,000
79,042,000,000
78,018,000,000
76,396,000,000
75,944,000,000
74,390,000,000
74,764,000,000
74,752,000,000
74,198,000,000
75,957,000,000
76,182,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.